{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:19:14Z","timestamp":1792016354079,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.exger.2004.04.012","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T17:34:08Z","timestamp":1097602448000},"page":"1723-1729","source":"Crossref","is-referenced-by-count":306,"title":["Melatonin, human aging, and age-related diseases"],"prefix":"10.1016","volume":"39","author":[{"given":"M.","family":"Karasek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2004.04.012_bib1","doi-asserted-by":"crossref","first-page":"PL23","DOI":"10.1016\/S0024-3205(96)00606-6","article-title":"Melatonin is protective against MPTP-induced striatal and hyppocampal lesions","volume":"60","author":"Acuna-Castroviejo","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.exger.2004.04.012_bib2","series-title":"Melatonin and the Mammalian Pineal Gland","author":"Arendt","year":"1995"},{"key":"10.1016\/j.exger.2004.04.012_bib3","first-page":"157","article-title":"Melatonin: the internal Zietgeber of mammals?","volume":"7","author":"Armstrong","year":"1989","journal-title":"Pineal Res. Rev."},{"key":"10.1016\/j.exger.2004.04.012_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0306-9877(91)90046-2","article-title":"Melatonin: a chronobiotic with anti-aging properties","volume":"34","author":"Armstrong","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.exger.2004.04.012_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/07853899808999394","article-title":"Guidelines for prescribing melatonin","volume":"30","author":"Avery","year":"1998","journal-title":"Ann. Med."},{"key":"10.1016\/j.exger.2004.04.012_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01256753","article-title":"Urinary melatonin levels in human breast cancer patients","volume":"52","author":"Bartsch","year":"1981","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.exger.2004.04.012_bib8","first-page":"377","article-title":"Circadian rhythms of serum melatonin, prolactin and growth hormone in patients with benign and malignant tumours of the prostate and in non-tumor controls","volume":"5","author":"Bartsch","year":"1983","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/1097-0142(19890715)64:2<426::AID-CNCR2820640215>3.0.CO;2-O","article-title":"Stage-dependent depression of melatonin in patients with primary breast cancer","volume":"64","author":"Bartsch","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.exger.2004.04.012_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/1097-0142(19910315)67:6<1681::AID-CNCR2820670634>3.0.CO;2-0","article-title":"Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism","volume":"67","author":"Bartsch","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.exger.2004.04.012_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0009-8981(92)90164-L","article-title":"Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations","volume":"209","author":"Bartsch","year":"1992","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib9","first-page":"30","article-title":"Melatonin in clinical oncology","volume":"23","author":"Bartsch","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/sleep\/24.4.418","article-title":"Melatonin in older people with age-related sleep maintenance problems: a comparison with age-matched normal sleepers","volume":"24","author":"Baskett","year":"2001","journal-title":"Sleep"},{"key":"10.1016\/j.exger.2004.04.012_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-079X.1999.tb00597.x","article-title":"Physiological levels of melatonin contribute to the antioxidant capacity of human serum","volume":"27","author":"Benot","year":"1999","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-079X.1995.tb00155.x","article-title":"Low and high melatonin excretors among healthy individuals","volume":"18","author":"Bergiannaki","year":"1995","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00075197-200201000-00002","article-title":"Free radical theory of aging","volume":"5","author":"Biesalski","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.exger.2004.04.012_bib16","series-title":"Melatonin\u2014Biosynthesis, Physiological Effects and Perspectives","first-page":"447","article-title":"Melatonin in oncology","author":"Blask","year":"1993"},{"key":"10.1016\/j.exger.2004.04.012_bib17","first-page":"111","article-title":"Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease","volume":"19","author":"Brusco","year":"1998","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1006\/bbrc.1994.1508","article-title":"\u03b2-Amyloid peptide free radical fragments initiate lipoperoxidation in a sequence specific fashion: implications to Alzheimer's disease","volume":"2000","author":"Buterfield","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exger.2004.04.012_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J. Neuroendocrinol."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib20","first-page":"20","article-title":"The use of melatonin in Anzheimer's disease","volume":"23","author":"Cardinali","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib21","first-page":"9","article-title":"Melatonin in sleep disorders and jet-lag","volume":"23","author":"Cardinali","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2741\/Chen","article-title":"Where do Alzheimer's plaques and tangles come from? Aging-induced protein degradation inefficiency","volume":"6","author":"Chen","year":"2001","journal-title":"Front. Biosci."},{"key":"10.1016\/j.exger.2004.04.012_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-079X.1998.tb00370.x","article-title":"Melatonin prevents \u03b2-amyloid-induced lipid peroxidation","volume":"24","author":"Daniels","year":"1998","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","article-title":"The oxidant stress hypothesis in Parkinson's disease: evidence supporting it","volume":"32","author":"Fahn","year":"1992","journal-title":"Ann. Neurobiol."},{"key":"10.1016\/j.exger.2004.04.012_bib25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","article-title":"Amyloidosis and Alzheimer's disease","volume":"54","author":"Ghiso","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exger.2004.04.012_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02786466","article-title":"The immune system in the elderly: I. Specific humoral immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02786467","article-title":"The immune system in the elderly: II. Specific cellular immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02786468","article-title":"The immune system in the elderly: III. Innate immunity","volume":"20","author":"Ginaldi","year":"1999","journal-title":"Immunol. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0306-4530(93)90025-G","article-title":"The role of melatonin and serotonin in aging: update","volume":"18","author":"Grad","year":"1993","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.exger.2004.04.012_bib30","series-title":"The Pineal Gland and Cancer","first-page":"408","article-title":"Mechanisms involved in the immunomodulatory effects of melatonin on the human immune system","author":"Gurrero","year":"2001"},{"key":"10.1016\/j.exger.2004.04.012_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","article-title":"Ageing: a theory based on free radical and radiation chemistry","volume":"11","author":"Harman","year":"1956","journal-title":"J. Gerontol."},{"key":"10.1016\/j.exger.2004.04.012_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0921-8734(92)90030-S","article-title":"Free radical theory of aging","volume":"275","author":"Harman","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib33","series-title":"The Pineal Gland and Cancer","first-page":"476","article-title":"Melatonin cancer therapy","author":"Hrushesky","year":"2001"},{"key":"10.1016\/j.exger.2004.04.012_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000060988","article-title":"Relationship between the pineal gland and experimentally-induced malignant tumors","volume":"23","author":"Karasek","year":"1997","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib35","first-page":"179","article-title":"Melatonin in humans: where we are 40 years after its discovery","volume":"20","author":"Karasek","year":"1999","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib36","first-page":"139","article-title":"Pineal gland, melatonin and cancer","volume":"20","author":"Karasek","year":"1999","journal-title":"Neuroendocrinol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib37","first-page":"80","article-title":"Serum melatonin circadian profile in women with adenocarcinoma of uterine corpus","volume":"4","author":"Karasek","year":"1996","journal-title":"Int. J. Thymol."},{"key":"10.1016\/j.exger.2004.04.012_bib38","first-page":"109","article-title":"Serum melatonin circadian profile in women suffering from the genital tract cancers","volume":"21","author":"Karasek","year":"2000","journal-title":"Neuroendocrinol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib39","first-page":"118","article-title":"Future of melatonin as a therapeutic agent","volume":"23","author":"Karasek","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-079X.1988.tb00651.x","article-title":"Plasma melatonin levels in patients suffering from colorectal carcinoma","volume":"5","author":"Khoory","year":"1988","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000213216","article-title":"Does centralized clock for aging exist?","volume":"36","author":"Kloeden","year":"1991","journal-title":"Gerontology"},{"key":"10.1016\/j.exger.2004.04.012_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0531-5565(93)90001-T","article-title":"Time-keeping in genetically programmed aging","volume":"28","author":"Kloeden","year":"1993","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2004.04.012_bib43","series-title":"The Pineal Gland and Cancer","first-page":"177","article-title":"Melatonin in patients with cancer of extra-reproductive location","author":"Kvetnaya","year":"2001"},{"key":"10.1016\/j.exger.2004.04.012_bib44","series-title":"The Pineal Gland and Cancer","first-page":"465","article-title":"Efficacy of melatonin in the immunotherapy of cancer using interleukin-2","author":"Lissoni","year":"2001"},{"key":"10.1016\/j.exger.2004.04.012_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/1097-0142(19860215)57:4<837::AID-CNCR2820570425>3.0.CO;2-O","article-title":"A clinical study of the pineal gland activity in oncologic patients","volume":"57","author":"Lissoni","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.exger.2004.04.012_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/13543784.10.3.467","article-title":"The immunotherapeutic potential of melatonin","volume":"10","author":"Maestroni","year":"2001","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.exger.2004.04.012_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1749-6632.1988.tb35272.x","article-title":"Pineal melatonin, its fundamental immunoregulatory role in aging and cancer","volume":"521","author":"Maestroni","year":"1988","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.exger.2004.04.012_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-079X.1998.tb00531.x","article-title":"Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease","volume":"24","author":"Mayo","year":"1998","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-079X.1998.tb00380.x","article-title":"Inhibition of cell proliferation: a mechanism likely to mediate prevention of neuronal death by melatonin","volume":"25","author":"Mayo","year":"1998","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib51","first-page":"119","article-title":"Sleep and aging","volume":"3","author":"Miles","year":"1980","journal-title":"Sleep"},{"key":"10.1016\/j.exger.2004.04.012_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0891-5849(96)00033-0","article-title":"Oxidative damage caused by free radicals produced during catocholamine autooxidation: protective effects of O-methylation and melatonin","volume":"21","author":"Miller","year":"1996","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.exger.2004.04.012_bib50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-3223(97)00510-6","article-title":"Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking","volume":"15","author":"Mishima","year":"1999","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.exger.2004.04.012_bib53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000014656","article-title":"A critical assessment of the melatonin effect on sleep in humans","volume":"9","author":"Monti","year":"2000","journal-title":"Biol. Signals Recept."},{"key":"10.1016\/j.exger.2004.04.012_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000425617","article-title":"Melatonin rhythm of Alzheimer patients","volume":"21","author":"Morita","year":"1996","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1568-1637(02)00014-4","article-title":"Senescence, sleep, and circadian rhythms","volume":"1","author":"Pandi-Perumal","year":"2002","journal-title":"Aging Res. Rev."},{"key":"10.1016\/j.exger.2004.04.012_bib55","first-page":"43","article-title":"Urinary 6-sulfatoxymelatonin levels in osteosarcoma: a case\u2013control study","volume":"26","author":"Panzer","year":"1998","journal-title":"Med. Sci. Res."},{"key":"10.1016\/j.exger.2004.04.012_bib65","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1523\/JNEUROSCI.17-05-01683.1997","article-title":"Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide","volume":"17","author":"Pappola","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exger.2004.04.012_bib66","series-title":"Alzheimer's Disease: Biology, Diagnosis and Therapeutics","first-page":"741","article-title":"Oxidative damage and cell death induced by an amyloid peptide fragment is completely prevented by melatonin","author":"Pappola","year":"1997"},{"key":"10.1016\/j.exger.2004.04.012_bib64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s007020050018","article-title":"An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease","volume":"107","author":"Pappola","year":"2000","journal-title":"J. Neural. Transm."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib57","first-page":"17","article-title":"Effects of six months melatonin treatment on sleep quality and serum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, and somatomedin C in elderly women","volume":"23","author":"Pawlikowski","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib58","first-page":"24","article-title":"Oncostatic action of melatonin: facts and question marks","volume":"23","author":"Pawlikowski","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib59","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0733-8619(05)70229-2","article-title":"Neuropathology of Alzheimer's disease and related disorders","volume":"18","author":"Perl","year":"2000","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.exger.2004.04.012_bib60","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.4049\/jimmunol.158.11.5163","article-title":"Diurnal rhythmicity of human cytokine production","volume":"158","author":"Petrovsky","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.exger.2004.04.012_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000213833","article-title":"Theoretical considerations on the nature of the pineal \u2018aging clock\u2019","volume":"43","author":"Pierpaoli","year":"1997","journal-title":"Gerontology"},{"key":"10.1016\/j.exger.2004.04.012_bib62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.91.2.787","article-title":"Pineal control of aging: effects of melatonin and pineal grafting in aging mice","volume":"91","author":"Pierpaoli","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.exger.2004.04.012_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1991.tb16987.x","article-title":"The pineal control of aging: the effects of melatonin and pineal grafting on survival of older mice","volume":"621","author":"Pierpaoli","year":"1991","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.exger.2004.04.012_bib67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0301-0082(98)00052-5","article-title":"Oxidative damage in the central nervous system: protection by melatonin","volume":"56","author":"Reiter","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.exger.2004.04.012_bib68","first-page":"103","article-title":"Antioxidant capacity of melatonin: a novel action not requiring a receptor","volume":"15","author":"Reiter","year":"1993","journal-title":"Neuroendocrinol. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib69","first-page":"3","article-title":"Melatonin: reducing molecular pathology and dysfunction die to free radicals and associated reactants","volume":"23","author":"Reiter","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib70","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1211\/002235702760345374","article-title":"Melatonin: reducing the toxicity and increasing the efficacy of drugs","volume":"54","author":"Reiter","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.exger.2004.04.012_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0306-9877(87)90054-5","article-title":"The role of melatonin and serotonin in aging","volume":"23","author":"Rozencweig","year":"1987","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.exger.2004.04.012_bib75","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00345-002-0258-3","article-title":"The aging male","volume":"20","author":"Schulman","year":"2002","journal-title":"World J. Urol."},{"key":"10.1016\/j.exger.2004.04.012_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0633.2002.290401.x","article-title":"Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment","volume":"29","author":"Seabra","year":"2000","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-079X.2001.300105.x","article-title":"Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle aged, and elderly patients","volume":"30","author":"Siegrist","year":"2001","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.exger.2004.04.012_bib76","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","article-title":"A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","volume":"26","author":"Singer","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.exger.2004.04.012_bib74","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress in Alzheimer's disease","volume":"1502","author":"Smith","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.exger.2004.04.012_bib77","first-page":"61","article-title":"Melatonin in immunity: comparative aspects","volume":"23","author":"Skwarlo-Sonta","year":"2002","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.exger.2004.04.012_bib78","series-title":"Department of Economic and Social Affairs. World Population Ageing: 1950\u20132050","author":"United Nations","year":"2001"},{"key":"10.1016\/j.exger.2004.04.012_bib79","series-title":"Population Division, Department of Economic and Social Affairs. World Population Prospects: the 2000 Revision. Highlights","author":"United Nations","year":"2001"},{"key":"10.1016\/j.exger.2004.04.012_bib80","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0531-5565(00)00191-1","article-title":"Circadian and sleep disturbances in the elderly","volume":"35","author":"Van Someren","year":"2000","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2004.04.012_bib81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000014574","article-title":"The use of melatonin for the treatment of insomnia","volume":"8","author":"Zisapel","year":"1999","journal-title":"Biol. Signals Recept."}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556504002876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556504002876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:53:10Z","timestamp":1682779990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556504002876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":81,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0531556504002876"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2004.04.012","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}